Barclays’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-122,925
| Closed | -$2.67M | – | 4285 |
|
|
2017
Q2 | $2.67M | Buy |
122,925
+111,008
| +932% | +$2.41M | ﹤0.01% | 1074 |
|
|
2017
Q1 | $167K | Buy |
11,917
+9,532
| +400% | +$134K | ﹤0.01% | 2603 |
|
|
2016
Q4 | $46K | Buy |
2,385
+1,457
| +157% | +$28.1K | ﹤0.01% | 2869 |
|
|
2016
Q3 | $16K | Buy |
928
+433
| +87% | +$7.47K | ﹤0.01% | 3121 |
|
|
2016
Q2 | $7K | Buy |
495
+300
| +154% | +$4.24K | ﹤0.01% | 3080 |
|
|
2016
Q1 | $3K | Sell |
195
-4,352
| -96% | -$67K | ﹤0.01% | 3186 |
|
|
2015
Q4 | $86K | Sell |
4,547
-6,007
| -57% | -$114K | ﹤0.01% | 2348 |
|
|
2015
Q3 | $179K | Buy |
10,554
+2,498
| +31% | +$42.4K | ﹤0.01% | 2160 |
|
|
2015
Q2 | $161K | Buy |
8,056
+1,108
| +16% | +$22.1K | ﹤0.01% | 2163 |
|
|
2015
Q1 | $118K | Sell |
6,948
-6,641
| -49% | -$113K | ﹤0.01% | 2454 |
|
|
2014
Q4 | $216K | Buy |
13,589
+1,962
| +17% | +$31.2K | ﹤0.01% | 2336 |
|
|
2014
Q3 | $255K | Sell |
11,627
-25,360
| -69% | -$556K | ﹤0.01% | 2204 |
|
|
2014
Q2 | $739K | Buy |
36,987
+28,652
| +344% | +$572K | ﹤0.01% | 1837 |
|
|
2014
Q1 | $151K | Buy |
8,335
+4,804
| +136% | +$87K | ﹤0.01% | 2534 |
|
|
2013
Q4 | $36K | Sell |
3,531
-1,206
| -25% | -$12.3K | ﹤0.01% | 3532 |
|
|
2013
Q3 | $57K | Buy |
4,737
+4,123
| +671% | +$49.6K | ﹤0.01% | 3157 |
|
|
2013
Q2 | $7K | Buy |
+614
| New | +$7K | ﹤0.01% | 3998 |
|